Figure 2From: Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands Incremental cost-effectiveness ratio of varying parameter values in univariate sensitivity analyses. Back to article page